Year: 2013
Type: article
Abstract: Next-generation sequencing (NGS) approaches for measuring RNA and DNA benefit from greatly increased sensitivity, dynamic range and detection of novel transcripts. These technologies are rapidly becoming the standard for molecular assays and represent huge potential value to the practice of oncology. However, many challenges exist in the transition of these technologies from research application to clinical practice. This review discusses the value of NGS in detecting mutations, copy number changes and RNA quantification and their applications in oncology, the challenges for adoption and the relevant steps that are needed for translating this potential to routine practice.
Source: Molecular Oncology
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
Funder: National Cancer Institute
Awards: G666505512, G7721780970
OpenAlex ID: W2130153722
